• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

零冠脉钙化无症状个体的胸主动脉钙化、心血管疾病事件及全因死亡率:动脉粥样硬化多民族研究(MESA)

Thoracic aortic calcium, cardiovascular disease events, and all-cause mortality in asymptomatic individuals with zero coronary calcium: The Multi-Ethnic Study of Atherosclerosis (MESA).

作者信息

Kim Joonseok, Budoff Matthew J, Nasir Khurram, Wong Nathan D, Yeboah Joseph, Al-Mallah Mouaz H, Shea Steve, Dardari Zeina A, Blumenthal Roger S, Blaha Michael J, Cainzos-Achirica Miguel

机构信息

Division of Cardiovascular Health and Disease, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45257, USA; Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Department of Cardiology, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.

Division of Cardiology, Los Angeles Biomedical Research Center at Harbor-UCLA, Division of Cardiology, Torrance, CA 90502, USA.

出版信息

Atherosclerosis. 2017 Feb;257:1-8. doi: 10.1016/j.atherosclerosis.2016.12.012. Epub 2016 Dec 10.

DOI:10.1016/j.atherosclerosis.2016.12.012
PMID:28033543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5325775/
Abstract

BACKGROUND AND AIMS

TAC is associated with incident CVD and all-cause mortality. Nevertheless, the independent 10-year prognostic value of TAC in individuals with CAC = 0 beyond traditional risk factors is not well established.

METHODS

3415 MESA participants with baseline CAC = 0 were followed for CHD, CVD events and all-cause mortality. TAC was measured in the ascending and descending aorta in all participants and quantified using Agatston's score. Multivariable Cox proportional hazards regression models were used to study the associations between TAC and incident CHD, CVD events and all-cause mortality. Likelihood ratio tests were used to compare prediction models including traditional risk factors plus TAC versus risk factors alone.

RESULTS

406 participants (11.9%) had TAC>0 at baseline. Over a median follow-up of 11.3 years, unadjusted event rates per 1000 person-years were higher in TAC>0 than in TAC = 0 participants: CHD 2.18 vs. 2.03; CVD 6.85 vs. 3.42; all-cause mortality 12.84 vs. 4.96. However, in multivariable Cox regression analyses adjusting for CVD risk factors, neither TAC>0, TAC>100 nor log(TAC+1) were independently associated with any of the study outcomes, nor improved their prediction compared to traditional risk factors alone (p value of likelihood ratio tests >0.05).

CONCLUSIONS

In a multi-ethnic, modern US population of asymptomatic individuals with CAC = 0 at baseline, the prevalence of TAC>0 was low, and TAC did not improve 10-year estimation of prognosis beyond traditional risk factors. In the presence of CAC = 0, measurement of TAC is unlikely to provide sufficient additional prognostic information to further improve risk assessment.

摘要

背景与目的

冠脉钙化积分(TAC)与心血管疾病(CVD)的发生及全因死亡率相关。然而,在无冠脉钙化(CAC)的个体中,TAC超过传统危险因素的独立10年预后价值尚未明确。

方法

对3415名基线CAC为0的多民族动脉粥样硬化社区研究(MESA)参与者进行冠心病(CHD)、CVD事件及全因死亡率随访。所有参与者均测量升主动脉和降主动脉的TAC,并采用阿加斯顿积分法进行量化。采用多变量Cox比例风险回归模型研究TAC与CHD、CVD事件及全因死亡率之间的关联。采用似然比检验比较包含传统危险因素加TAC的预测模型与仅包含危险因素的预测模型。

结果

406名参与者(11.9%)基线时TAC>0。在中位随访11.3年期间,每1000人年未调整的事件发生率在TAC>0的参与者中高于TAC = 0的参与者:CHD分别为2.18和2.03;CVD分别为6.85和3.42;全因死亡率分别为12.84和4.96。然而,在调整CVD危险因素的多变量Cox回归分析中,TAC>0、TAC>100或log(TAC + 1)均与任何研究结局无独立关联,与仅使用传统危险因素相比,也未改善其预测能力(似然比检验p值>0.05)。

结论

在基线CAC = 0的多民族、现代美国无症状个体人群中,TAC>0的患病率较低,且TAC并未改善传统危险因素以外的10年预后估计。在CAC = 0的情况下,测量TAC不太可能提供足够的额外预后信息以进一步改善风险评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fdb/5325775/a4951fecf89e/nihms839347f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fdb/5325775/9c27b1355436/nihms839347f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fdb/5325775/e4090ac630e8/nihms839347f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fdb/5325775/a4951fecf89e/nihms839347f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fdb/5325775/9c27b1355436/nihms839347f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fdb/5325775/e4090ac630e8/nihms839347f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fdb/5325775/a4951fecf89e/nihms839347f3.jpg

相似文献

1
Thoracic aortic calcium, cardiovascular disease events, and all-cause mortality in asymptomatic individuals with zero coronary calcium: The Multi-Ethnic Study of Atherosclerosis (MESA).零冠脉钙化无症状个体的胸主动脉钙化、心血管疾病事件及全因死亡率:动脉粥样硬化多民族研究(MESA)
Atherosclerosis. 2017 Feb;257:1-8. doi: 10.1016/j.atherosclerosis.2016.12.012. Epub 2016 Dec 10.
2
Computed tomography-derived cardiovascular risk markers, incident cardiovascular events, and all-cause mortality in nondiabetics: the Multi-Ethnic Study of Atherosclerosis.计算机断层扫描衍生的心血管风险标志物、非糖尿病患者的心血管事件发生率和全因死亡率:动脉粥样硬化多民族研究
Eur J Prev Cardiol. 2014 Oct;21(10):1233-41. doi: 10.1177/2047487313492065. Epub 2013 May 20.
3
Greater Volume but not Higher Density of Abdominal Aortic Calcium Is Associated With Increased Cardiovascular Disease Risk: MESA (Multi-Ethnic Study of Atherosclerosis).腹主动脉钙化体积增大而非密度增加与心血管疾病风险升高相关:动脉粥样硬化多民族研究(MESA)
Circ Cardiovasc Imaging. 2016 Nov;9(11). doi: 10.1161/CIRCIMAGING.116.005138.
4
Thoracic aortic calcium versus coronary artery calcium for the prediction of coronary heart disease and cardiovascular disease events.胸主动脉钙化与冠状动脉钙化对冠心病和心血管疾病事件的预测作用
JACC Cardiovasc Imaging. 2009 Mar;2(3):319-26. doi: 10.1016/j.jcmg.2008.12.010.
5
Cardiovascular Event Prediction and Risk Reclassification by Coronary, Aortic, and Valvular Calcification in the Framingham Heart Study.弗雷明汉心脏研究中冠状动脉、主动脉和瓣膜钙化对心血管事件的预测及风险重新分类
J Am Heart Assoc. 2016 Feb 22;5(2):e003144. doi: 10.1161/JAHA.115.003144.
6
Abdominal aortic calcium, coronary artery calcium, and cardiovascular morbidity and mortality in the Multi-Ethnic Study of Atherosclerosis.腹主动脉钙、冠状动脉钙与心血管疾病发病和死亡风险:动脉粥样硬化的多种族研究。
Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1574-9. doi: 10.1161/ATVBAHA.114.303268. Epub 2014 May 8.
7
Association of progressive thoracic aortic calcification with future cardiovascular events and all-cause mortality: ability to improve risk prediction? Results of the Heinz Nixdorf Recall (HNR) study.胸主动脉进行性钙化与未来心血管事件和全因死亡率的关系:改善风险预测的能力?海因茨·尼克斯多夫召回研究(HNR)的结果。
Eur Heart J Cardiovasc Imaging. 2019 Jun 1;20(6):709-717. doi: 10.1093/ehjci/jey173.
8
Thoracic Aorta Calcification and Noncardiovascular Disease-Related Mortality.胸主动脉钙化与非心血管疾病相关死亡率。
Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1926-1932. doi: 10.1161/ATVBAHA.118.310850.
9
Sex Differences in Coronary Artery and Thoracic Aorta Calcification and Their Association With Cardiovascular Mortality in Heavy Smokers.重度吸烟者冠状动脉和胸主动脉钙化的性别差异及其与心血管死亡率的关系。
JACC Cardiovasc Imaging. 2019 Sep;12(9):1808-1817. doi: 10.1016/j.jcmg.2018.10.026. Epub 2019 Jan 16.
10
Thoracic versus coronary calcification for atherosclerotic cardiovascular disease events prediction.胸主动脉钙化与冠状动脉钙化对动脉粥样硬化性心血管疾病事件的预测价值。
Heart. 2024 Jun 25;110(14):947-953. doi: 10.1136/heartjnl-2023-323838.

引用本文的文献

1
Determinants of thoracic aortic calcification and its effects on thoracic aortic size.胸主动脉钙化的决定因素及其对胸主动脉大小的影响。
Int J Cardiovasc Imaging. 2025 Jul 31. doi: 10.1007/s10554-025-03481-z.
2
Thoracic aortic calcification as a predictor of coronary artery disease: a systematic review and meta-analysis.胸主动脉钙化作为冠状动脉疾病的预测指标:一项系统评价和荟萃分析。
J Pathol Transl Med. 2025 May;59(3):161-170. doi: 10.4132/jptm.2025.03.05. Epub 2025 Apr 30.
3
Inactive Matrix Gla Protein and Cardiovascular Outcomes: The Multi-Ethnic Study of Atherosclerosis.

本文引用的文献

1
Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention: importance to implementation of the 2013 ACC/AHA Guidelines.临床医生与患者关于动脉粥样硬化性心血管疾病预防的风险讨论:对实施2013年美国心脏病学会/美国心脏协会指南的重要性。
J Am Coll Cardiol. 2015 Apr 7;65(13):1361-1368. doi: 10.1016/j.jacc.2015.01.043.
2
Thoracic aortic calcification is associated with incident stroke in the general population in addition to established risk factors.胸主动脉钙化除了与已确定的危险因素外,还与一般人群中的中风事件有关。
Eur Heart J Cardiovasc Imaging. 2015 Jun;16(6):684-90. doi: 10.1093/ehjci/jeu293. Epub 2014 Dec 30.
3
无活性基质Gla蛋白与心血管结局:动脉粥样硬化多民族研究
J Am Heart Assoc. 2025 Mar 4;14(5):e036459. doi: 10.1161/JAHA.124.036459. Epub 2025 Feb 19.
4
Association of thoracic aortic calcium with incident cardiovascular disease and all-cause mortality across the spectrum of coronary artery calcium burden.在冠状动脉钙化负担的整个范围内,胸主动脉钙化与心血管疾病发病及全因死亡率的关联。
Am J Prev Cardiol. 2025 Jan 2;21:100916. doi: 10.1016/j.ajpc.2024.100916. eCollection 2025 Mar.
5
Beyond the Agatston calcium score: role of calcium density and other calcified plaque markers for cardiovascular disease prediction.超越阿加斯顿钙评分:钙密度及其他钙化斑块标志物在心血管疾病预测中的作用
Curr Opin Cardiol. 2025 Jan 1;40(1):56-62. doi: 10.1097/HCO.0000000000001185. Epub 2024 Oct 9.
6
The Predictive Value of Aortic Calcification on Computed Tomography for Major Cardiovascular Events.计算机断层扫描中主动脉钙化对主要心血管事件的预测价值
J Clin Med. 2024 Jul 10;13(14):4019. doi: 10.3390/jcm13144019.
7
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies.无症状人群体内亚临床动脉粥样硬化的评估:适合生物标志物和孟德尔随机化研究的测量方法。
Arterioscler Thromb Vasc Biol. 2024 Jan;44(1):24-47. doi: 10.1161/ATVBAHA.123.320138. Epub 2023 Nov 21.
8
An update on the coronary calcium score: a review for clinicians.冠状动脉钙化积分最新进展:临床医生综述
Postepy Kardiol Interwencyjnej. 2022 Sep;18(3):201-205. doi: 10.5114/aic.2022.121035. Epub 2022 Dec 23.
9
Extra-coronary Calcification and Cardiovascular Events: What Do We Know and Where Are We Heading?冠状动脉外钙化与心血管事件:我们了解什么?未来方向如何?
Curr Atheroscler Rep. 2022 Oct;24(10):755-766. doi: 10.1007/s11883-022-01051-5. Epub 2022 Aug 30.
10
Role of the coronary and non-coronary cardiovascular findings on non-cardiac gated thoracic CT in predicting mortality in SARS-CoV-2 infection.非心脏门控胸部 CT 的冠状动脉和非冠状动脉心血管表现对 SARS-CoV-2 感染患者死亡率的预测作用。
Clin Imaging. 2022 Sep;89:49-54. doi: 10.1016/j.clinimag.2022.06.002. Epub 2022 Jun 9.
Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort. The MESA Study.
无症状队列中的冠状动脉钙化与新发脑血管事件。多民族动脉粥样硬化研究(MESA研究)
JACC Cardiovasc Imaging. 2014 Nov;7(11):1108-15. doi: 10.1016/j.jcmg.2014.07.009. Epub 2014 Nov 10.
4
Abdominal aortic calcium, coronary artery calcium, and cardiovascular morbidity and mortality in the Multi-Ethnic Study of Atherosclerosis.腹主动脉钙、冠状动脉钙与心血管疾病发病和死亡风险:动脉粥样硬化的多种族研究。
Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1574-9. doi: 10.1161/ATVBAHA.114.303268. Epub 2014 May 8.
5
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会成人降低动脉粥样硬化性心血管风险的血胆固醇治疗指南:美国心脏病学会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934. doi: 10.1016/j.jacc.2013.11.002. Epub 2013 Nov 12.
6
Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis.血脂异常、冠状动脉钙和动脉粥样硬化性心血管疾病的发生:来自动脉粥样硬化多民族研究的他汀类药物治疗意义。
Circulation. 2014 Jan 7;129(1):77-86. doi: 10.1161/CIRCULATIONAHA.113.003625. Epub 2013 Oct 20.
7
Coronary artery calcium for the prediction of mortality in young adults <45 years old and elderly adults >75 years old.冠状动脉钙对 45 岁以下的年轻人和 75 岁以上的老年人的死亡率预测。
Eur Heart J. 2012 Dec;33(23):2955-62. doi: 10.1093/eurheartj/ehs230. Epub 2012 Jul 26.
8
Mitochondrial oxidative stress in aortic stiffening with age: the role of smooth muscle cell function.随着年龄的增长,主动脉僵硬中的线粒体氧化应激:平滑肌细胞功能的作用。
Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):745-55. doi: 10.1161/ATVBAHA.111.243121. Epub 2011 Dec 22.
9
Aortic stiffness: current understanding and future directions.主动脉僵硬:当前的认识和未来方向。
J Am Coll Cardiol. 2011 Apr 5;57(14):1511-22. doi: 10.1016/j.jacc.2010.12.017.
10
Understanding the utility of zero coronary calcium as a prognostic test: a Bayesian approach.理解零冠状动脉钙化作为一种预后测试的效用:一种贝叶斯方法。
Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):253-6. doi: 10.1161/CIRCOUTCOMES.110.958496.